Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence.

Alsagaff MY, Mulia EPB.

Open source

DOI: 10.1016/j.ihj.2021.10.011
Published: 2021-10-27
Container: Indian Heart J
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ihj.2021.10.011,
  title = {Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence.},
  author = {Alsagaff MY and  Mulia EPB.},
  year = {2021},
  journal = {Indian Heart J},
  doi = {10.1016/j.ihj.2021.10.011},
  url = {https://doi.org/10.1016/j.ihj.2021.10.011}
}

RIS

TY  - JOUR
TI  - Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence.
AU  - Alsagaff MY
AU  -  Mulia EPB.
PY  - 2021
JO  - Indian Heart J
DO  - 10.1016/j.ihj.2021.10.011
UR  - https://doi.org/10.1016/j.ihj.2021.10.011
ER  -

APA

MY, A., & EPB., M. (2021). Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence.. Indian Heart J. https://doi.org/10.1016/j.ihj.2021.10.011

Source records

europe-pmc · retrieved 2026-09-27T04:04:08.379Z
doaj · retrieved 2026-09-27T04:04:08.382Z